 | Mersana Therapeutics, Inc. | |||
| NMS : MRSN || Location: United States | ||||
$3.25-0.09 (-2.69%) |
2.39 M | 3.18 - 3.35 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 10.134 M |
| March 15, 2024 | 8.726 M |
| Feb. 29, 2024 | 7.140 M |
| Feb. 15, 2024 | 7.098 M |
| Jan. 31, 2024 | 6.653 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.17 | -0.16 | 4.53% |
| 09/30/2023 | -0.37 | -0.27 | 26.85% |
| 06/30/2023 | -0.45 | -0.47 | -4.37% |
| 03/31/2023 | -0.44 | -0.52 | -16.99% |
| 12/31/2022 | -0.51 | -0.44 | 14.48% |
MRSN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 121.303M | Shares Float | 64.306M |
| Short Float | 10.134M | Market Cap | 394.23M |
| Institution ownership | 95.23% | Insider ownership | 1.329% |
| Earnings Date | 05/06/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.48 | Forward EPS | -0.73 |